Products for Research Use Only
RegisterLogin

CCG 203769

CAT: 0804-HY-U00431-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-U00431-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CCG 203769 is a selective G protein signaling (RGS4) inhibitor, which blocks the RGS4-Gαo protein-protein interaction in vitro with an IC50 of 17 nM.
CAS Number
410074-60-1
UNSPSC
12352005
Target
RGS Protein
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/CCG_203769.html
Purity
99.76
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(N1CCCC)N(CC)SC1=O
Molecular Formula
C8H14N2O2S
Molecular Weight
202.27
References & Citations
[1]Blazer LL, et al. Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors. ACS Chem Neurosci. 2015 Jun 17;6 (6) :911-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RGS16; RGS19; RGS4; RGS8

Related Products

CatalogName
HY-150040CCG-273463
HY-13991-01CCG-1423
HY-130011CCG-232964
HY-122251CCG-4986
HY-111432CCG-232601
HY-70074-01CCG-63802
HY-110054CCG-2046
HY-108361-01CCG-203971
HY-120855-01CCG-100602
HY-70075-01CCG-63808

Alternative Products

CatalogName
MBS3614743-01CCG 203769

Popular Products